Short answer
Factor V Leiden is a specific variant in the F5 gene that reduces normal inactivation of factor V and makes venous clotting more likely. Testing may be a DNA test for the variant or, in some settings, a functional activated protein C resistance assay. A positive result changes risk assessment, but it does not mean a person has a clot now or automatically needs lifelong anticoagulation.
What the test measures
| Test type | What it answers | What to remember |
|---|---|---|
| DNA test for F5 variant | Looks for the Factor V Leiden change itself. | Useful for confirmation and family follow-up. |
| Activated protein C resistance | Looks for an abnormal clotting response that can suggest FVL. | Some labs use it as a screen before or alongside DNA testing. |
| Thrombophilia panel | Looks for several inherited and acquired clotting risks at once. | Best used when the result will change a real decision. |
When testing is useful
| Scenario | Why it matters | What to clarify |
|---|---|---|
| Personal history of DVT or PE | May help refine counseling in selected cases. | Was the clot provoked by surgery, estrogen, pregnancy, cancer, or immobility? |
| Known family variant | Targeted testing can help confirm inherited risk. | Who in the family was tested, and what exact result was found? |
| Pregnancy or estrogen decisions | May affect contraceptive or pregnancy planning when it changes management. | Discuss with an OB-GYN, hematologist, or clinician familiar with thrombophilia. |
| Unusual-site or recurrent VTE | Can be part of a broader thrombophilia workup. | What other inherited or acquired causes still need attention? |
When routine screening is not the move
Routine population screening is usually not helpful. GeneReviews and ASH both caution against broad testing in people without a clear decision point, and CDC contraception guidance says thrombophilia screening is not needed for safe initiation of combined hormonal contraceptives in the general population. A test is most valuable when it will change management, counseling, or family follow-up.
What a positive or negative result means
Heterozygous results usually carry less risk than homozygous results, but neither result guarantees a clot. Age, surgery, immobility, estrogen exposure, pregnancy, cancer, smoking, obesity, and prior clot history still matter. A negative Factor V Leiden test does not rule out every clotting disorder or every acquired reason for clot risk.
Questions to ask
- Was this a DNA test, an APC resistance screen, or a broader thrombophilia panel?
- Am I heterozygous or homozygous, and how does that change my risk?
- Would the result change contraception, hormone therapy, pregnancy planning, surgery precautions, or travel advice?
- Should relatives be tested, or is family counseling a better next step?
FAQ
Is Factor V Leiden the same as Factor V deficiency?
No. Factor V Leiden is a clot-risk variant; Factor V deficiency is a bleeding disorder.
Can I have Factor V Leiden if my PT and aPTT are normal?
Yes. Those routine clotting tests do not rule out Factor V Leiden.
Do I need testing before birth control or estrogen therapy?
Not routinely as a population screen. Testing becomes more relevant when there is a personal clot history, a known family variant, or a specific clinical question.
Does a positive test mean I need blood thinners forever?
No. Anticoagulation decisions depend on the clot history, provoking factors, and overall risk profile.
Should my family be tested?
Sometimes, but family testing is usually targeted and decision-based rather than automatic.
What if Factor V Leiden is negative but I still had a clot?
Then other inherited or acquired causes may still be present, and the clot still needs its own explanation.
Related guides: hereditary thrombophilia testing, prothrombin G20210A testing, protein C, protein S, and antithrombin testing, and antiphospholipid syndrome antibody testing.